In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.

American Century Companies Inc. gave Amgen a financial haircut, slashing its stake by 46.3% and cashing in $36.76 million.

The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk ...